Skip to content

Retrospectively Investigating Longitudinal Outcomes in MED-EL SONATA 2 Cochlear Implant Recipients.

Longitudinal Outcomes of SONATA 2 Cochlear Implant Recipients: a Retrospective Study

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07697911
Acronym
LORIS
Enrollment
200
Registered
2026-07-13
Start date
2026-09-01
Completion date
2027-05-01
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cochlear Implantation, Sensorineural Hearing Loss

Keywords

retrospective data collection

Brief summary

MED-EL Cochlear Implants (CI) provide auditory sensations via electrical stimulation of the auditory pathways for severely to profoundly hearing-impaired individuals who obtain little or no benefit from acoustic amplification in the best aided condition. However, there is only few evidence from large long-term observational studies available to gain knowledge on clinical effectiveness of cochlear implants. With continued pressure on healthcare system budgets, there is an increasing demand for evidence-based research that demonstrates an intervention is effective in the real-world environment across large and diverse populations. Currently, there is a paucity of data concerning the long-term outcomes of subjects implanted with a SONATA 2 cochlear implant from representative samples of the population. This retrospective study aims at analyzing SONATA 2 cochlear implant data from clinical routine.

Detailed description

Data from SONATA 2 CI recipients will be transferred to predefined fields in an electronic data capture system (CASTOR EDC) by the investigators. The data transfer starts after the approval of the Ethics Committees (EC). Data will be included for all subjects who meet the inclusion/exclusion criteria

Interventions

OTHERTransfer of data of SONATA 2 cochlear implant recipients

Data from SONATA 2 cochlear implant recipients is transferred to CASTOR EDC

Sponsors

MED-EL Elektromedizinische Geräte GesmbH
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* At least one MED-EL SONATA 2 cochlear implant with a compatible MED-EL audio processor

Exclusion criteria

* Lack of compliance with any inclusion criteria

Design outcomes

Primary

MeasureTime frame
Bisyllables recognition score in quietpre-operative to 5 years post-operative

Secondary

MeasureTime frameDescription
Bisyllables recognition score in noisepre-operative to 5 years post-operative
Wearing timeup to 5 years post-operativeWearing time in hours of audio processor used together with SONATA 2 cochlear implant
Device parameterup to 5 years post-operativeDescriptive summary of which electrode type was used together with a SONATA 2 cochlear implant
Demographic informationpre-operativedescriptive summary of demographics
Complications related to the device or procedureup to 5 years post-operative
Questionnaire scorespre-operative to 5 years post-operativeHearing Implant Sound Quality Index (HISQUI19). Total score range from 19 to 133 points. The higher the score the better the outcome.

Countries

Spain

Contacts

CONTACTJasmine Rinnofner
jasmine.rinnofner@medel.com+43577881694

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 11, 2026